QTRX
Quanterix Corp.
NASDAQ · Healthcare · Medical - Devices · US
$2.77
−3.48%Year over year
Reported trailing growth
- Revenue
- +23.4%
- EBITDA
- -39.1%
- EBIT
- -46.9%
- EPS
- -44.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.7%
- EBITDA
- +57.2%
- EPS
- +46.0%
Three-year CAGR
- Revenue
- +9.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026